| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1152/AJPCELL.00406.2006 |
| P8608 | Fatcat ID | release_ygkvkzjox5c43admtfben6k7ni |
| P3181 | OpenCitations bibliographic resource ID | 1801228 |
| P698 | PubMed publication ID | 16943240 |
| P5875 | ResearchGate publication ID | 6846027 |
| P50 | author | Ilona Kryczek | Q88866814 |
| P2093 | author name string | Evan Keller | |
| Rebecca Liu | |||
| Shuang Wei | |||
| Weiping Zou | |||
| P2860 | cites work | Involvement of chemokine receptors in breast cancer metastasis | Q24290909 |
| Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway | Q24558745 | ||
| CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells | Q48354586 | ||
| CXC chemokine receptor 4 expression and function in human astroglioma cells | Q49071824 | ||
| Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. | Q51994210 | ||
| Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). | Q52540929 | ||
| CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro. | Q52567305 | ||
| CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. | Q52834072 | ||
| Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. | Q53276834 | ||
| Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow. | Q54403966 | ||
| Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. | Q54669043 | ||
| Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. | Q54692947 | ||
| Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions | Q57265377 | ||
| Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury | Q47653534 | ||
| Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo | Q47895026 | ||
| Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma | Q47951335 | ||
| Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells | Q24563114 | ||
| B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma | Q24676809 | ||
| Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice | Q24681021 | ||
| Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome | Q24814632 | ||
| Targeting HIF-1 for cancer therapy | Q27860504 | ||
| Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer | Q27860681 | ||
| Active movement of T cells away from a chemokine | Q28114990 | ||
| A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer | Q28183621 | ||
| Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth | Q28203327 | ||
| Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway | Q28237035 | ||
| The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes | Q28267757 | ||
| The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract | Q28504884 | ||
| A role for hematopoietic stem cells in promoting angiogenesis | Q28508896 | ||
| Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development | Q28512895 | ||
| Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion | Q29547317 | ||
| Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 | ||
| New functions for the matrix metalloproteinases in cancer progression | Q29547738 | ||
| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
| Dissemination and growth of cancer cells in metastatic sites | Q29555846 | ||
| TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB | Q29614706 | ||
| Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 | Q29615241 | ||
| Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 | Q29616092 | ||
| Immunosuppressive networks in the tumour environment and their therapeutic relevance | Q29619244 | ||
| Molecular characterization of the tumor microenvironment in breast cancer | Q31095898 | ||
| Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. | Q33217202 | ||
| Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. | Q33362778 | ||
| Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter | Q33936032 | ||
| Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers | Q33979799 | ||
| Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells | Q34103579 | ||
| CXCR4: chemokine receptor extraordinaire | Q34118771 | ||
| CXCR4/CXCL12 expression and signalling in kidney cancer | Q34123763 | ||
| Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist | Q34412254 | ||
| Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis | Q34418159 | ||
| Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow | Q34488568 | ||
| The role of chemokines in linking innate and adaptive immunity | Q34493082 | ||
| Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo | Q34503877 | ||
| Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer | Q34530109 | ||
| Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells | Q34540019 | ||
| Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications | Q35053933 | ||
| Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas | Q35094629 | ||
| The bicyclam AMD3100 story | Q35158014 | ||
| Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development | Q35581768 | ||
| Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. | Q35786830 | ||
| Chemokines in neoplastic progression | Q35832347 | ||
| Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. | Q36369295 | ||
| Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells | Q36370232 | ||
| Regulation of the chemokine receptor CXCR4 by hypoxia | Q36371842 | ||
| Regulatory T cells, tumour immunity and immunotherapy | Q36430144 | ||
| A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer | Q36509678 | ||
| Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis | Q36569348 | ||
| Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins | Q36766113 | ||
| A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. | Q37089440 | ||
| Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells | Q38336314 | ||
| CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2. | Q39261197 | ||
| Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer | Q40314315 | ||
| Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation | Q40355298 | ||
| Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy | Q40367379 | ||
| CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation | Q40381071 | ||
| Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor | Q40396846 | ||
| Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation | Q40416189 | ||
| Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma | Q40429792 | ||
| CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture | Q40432536 | ||
| CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. | Q40439589 | ||
| Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypox | Q40440548 | ||
| Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer. | Q40463013 | ||
| Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. | Q40490606 | ||
| CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion | Q40507455 | ||
| Evaluation of tissue-specific promoters in carcinomas of the cervix uteri | Q40515541 | ||
| CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma | Q40516360 | ||
| Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. | Q40543795 | ||
| Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma | Q40555406 | ||
| Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. | Q40633683 | ||
| Involvement of dipeptidyl peptidase IV in extravillous trophoblast invasion and differentiation | Q40706152 | ||
| G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. | Q40724468 | ||
| Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function | Q40736018 | ||
| Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells | Q40778652 | ||
| Loss of chemokine SDF-1alpha-mediated CXCR4 signalling and receptor internalization in human hepatoma cell line HepG2. | Q40804046 | ||
| Characterization and visualization of [125I] stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells. | Q40850285 | ||
| SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models. | Q40856670 | ||
| Molecular characterization of CXCR-4: a potential brain tumor-associated gene | Q40982090 | ||
| Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene | Q41312923 | ||
| Chemokine receptor expression by human intestinal epithelial cells | Q41681584 | ||
| Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells | Q42437094 | ||
| Characterization of an imatinib-sensitive subset of high-grade human glioma cultures | Q42804376 | ||
| Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. | Q42823593 | ||
| The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases | Q43671920 | ||
| Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells | Q43713989 | ||
| Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. | Q44645796 | ||
| Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells | Q44803162 | ||
| Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells | Q45309109 | ||
| Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas | Q47376060 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| P304 | page(s) | C987-95 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | American Journal of Physiology - Cell Physiology | Q2227080 |
| P1476 | title | Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis | |
| P478 | volume | 292 |
| Q41843794 | A Broad G Protein-Coupled Receptor Internalization Assay that Combines SNAP-Tag Labeling, Diffusion-Enhanced Resonance Energy Transfer, and a Highly Emissive Terbium Cryptate |
| Q36143512 | A C. elegans Myc-like network cooperates with semaphorin and Wnt signaling pathways to control cell migration |
| Q40525129 | A joint frailty-copula model between tumour progression and death for meta-analysis |
| Q47679355 | A polysaccharide from Dictyophora indusiata inhibits the immunosuppressive function of cancer-associated fibroblasts. |
| Q91168620 | ATF3 and JDP2 deficiency in cancer associated fibroblasts promotes tumor growth via SDF-1 transcription |
| Q36085659 | Aberrant CXCR4 and β-catenin expression in osteosarcoma correlates with patient survival |
| Q34980277 | Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow |
| Q36730776 | Beneficial effect of a CXCR4 agonist in murine models of systemic inflammation |
| Q27693321 | Bioinformatic analysis of HIV-1 entry and pathogenesis |
| Q34471954 | C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells |
| Q34468655 | CD133+ and Nestin+ Glioma Stem-Like Cells Reside Around CD31+ Arterioles in Niches that Express SDF-1α, CXCR4, Osteopontin and Cathepsin K. |
| Q31056366 | CXCL12 and [N33A]CXCL12 in 5637 and HeLa cells: regulating HER1 phosphorylation via calmodulin/calcineurin. |
| Q33848551 | CXCL12 expression by healthy and malignant ovarian epithelial cells. |
| Q47228301 | CXCL12 gene silencing down-regulates metastatic potential via blockage of MAPK/PI3K/AP-1 signaling pathway in colon cancer. |
| Q85719875 | CXCL12 induces lung cancer cell migration by polarized mtDNA redistribution |
| Q35854388 | CXCL12 rs266085 and TNF-α rs1799724 polymorphisms and susceptibility to cervical cancer in a Chinese population. |
| Q34151630 | CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis |
| Q36879569 | CXCL12/CXCR4 axis induces proliferation and invasion in human endometrial cancer |
| Q34476278 | CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells |
| Q37649217 | CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. |
| Q49541054 | CXCL12/CXCR4/CXCR7 Chemokine Axis in the Central Nervous System: Therapeutic Targets for Remyelination in Demyelinating Diseases. |
| Q38472331 | CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks |
| Q50066553 | CXCL12γ Promotes Development of Metastatic Castration Resistant Prostate Cancer by Induction of Cancer Stem Cell and Neuroendocrine Phenotypes. |
| Q58783862 | CXCR4-directed theranostics in oncology and inflammation |
| Q36451759 | CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver |
| Q42836312 | Cancer. Awakening immunity |
| Q35962518 | Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation. |
| Q33883005 | Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. |
| Q38170150 | Cellular and molecular mechanisms in cancer immune escape: a comprehensive review |
| Q35573448 | Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells |
| Q33495586 | Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization |
| Q33792344 | Chemokines as Cancer Vaccine Adjuvants. |
| Q38223355 | Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment |
| Q39337489 | Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy |
| Q92735170 | Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα |
| Q26823035 | Circulating biomarkers of response to sunitinib in gastroenteropancreatic neuroendocrine tumors: current data and clinical outlook |
| Q34189559 | Clinicopathologic significance of HIF-1α, CXCR4, and VEGF expression in colon cancer |
| Q35871574 | Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis |
| Q53132108 | Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis. |
| Q36011854 | Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer |
| Q34028966 | Co-expression of uPAR and CXCR4 promotes tumor growth and metastasis in small cell lung cancer |
| Q41747636 | Combined treatment with a CXCL12 analogue and antibiotics improves survival and neutrophil recruitment and function in murine sepsis |
| Q22000754 | Contribution of CXCL12 secretion to invasion of breast cancer cells. |
| Q37362080 | Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer. |
| Q42491492 | DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts |
| Q37584726 | De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes. |
| Q36052856 | Decreased CXCL12 is associated with impaired alveolar epithelial cell migration and poor lung healing after lung resection |
| Q36757178 | Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer |
| Q34649397 | Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies. |
| Q35752620 | Dermal fibroblast expression of stromal cell-derived factor-1 (SDF-1) promotes epidermal keratinocyte proliferation in normal and diseased skin |
| Q33827674 | Dietary intake of a plant phospholipid/lipid conjugate reduces lung cancer growth and tumor angiogenesis. |
| Q50992850 | Differential expression of visfatin, leptin, stromal cell derived factor-1α, endothelial nitric oxide synthase, and vascular endothelial growth factor in human leiomyomas. |
| Q35787278 | EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma |
| Q38933315 | Effect of the LPA-mediated CXCL12-CXCR4 axis in the tumor proliferation, migration and invasion of ovarian cancer cell lines |
| Q47849841 | Effects of L-selectin stimulation of the expression of chemokine receptor CXCR4 on NK cells of healthy donors and tumor patients |
| Q37672797 | Effects of preemptive intravenous lornoxicam on the analgesic efficacy of epidural morphine and expression of chemokines in women undergoing hysterectomy |
| Q34380220 | Elevated expression of CXC chemokines in pediatric osteosarcoma patients |
| Q34881148 | Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER-CXCL12-CXCR4 signaling axis |
| Q35178939 | Enhancement of T cell recruitment and infiltration into tumours. |
| Q33597520 | Expression of CXCL12 and its receptor CXCR4 in patients with adenomyosis |
| Q38933359 | Expression of SDF-1 and CXCR4 transcript variants and CXCR7 in epithelial ovarian cancer |
| Q85197747 | Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma |
| Q30438828 | Functional reconstitution of the human chemokine receptor CXCR4 with G(i)/G (o)-proteins in Sf9 insect cells |
| Q37551663 | Gastric and colon metastasis from breast cancer: case report, review of the literature, and possible underlying mechanisms |
| Q44671365 | Gene expression changes after ionizing radiation in endothelial cells derived from human endometrial cancer-preliminary outcomes |
| Q38823562 | Heme Oxygenases in Cardiovascular Health and Disease |
| Q39226075 | Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4. |
| Q26852845 | Heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesis |
| Q92713823 | High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma |
| Q41964485 | Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions |
| Q34582152 | Identification of multiple genes and their expression profiles in four strains of Oreochromis spp. in response to Streptococcus iniae |
| Q38934352 | Identification of transcription factors involved in the transcriptional regulation of the CXCL12 gene in rat pancreatic insulinoma Rin-5F cell line |
| Q35116822 | Immunohistochemical detection of the CXCR4 expression in tumor tissue using the fluorescent peptide antagonist Ac-TZ14011-FITC. |
| Q27011420 | Immunohistochemical expression of CXCR4 on breast cancer and its clinical significance |
| Q49592831 | Immunotherapeutic Targeting of Tumor-Associated Blood Vessels |
| Q57082684 | Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts |
| Q38241160 | Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology. |
| Q37660923 | Incretin therapy and pancreatic pathologies: background pathology versus drug-induced pathology in rats |
| Q33907157 | Inflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis |
| Q40994190 | Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma |
| Q52683626 | Inhibitors of HIF-1α and CXCR4 Mitigate the Development of Radiation Necrosis in Mouse Brain. |
| Q39859924 | Inhibitory effect of fucoidan on Huh7 hepatoma cells through downregulation of CXCL12. |
| Q40058610 | Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences. |
| Q37945305 | Intrinsic modulation of lymphocyte function by stromal cell network: advance in therapeutic targeting of cancer |
| Q37226145 | Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo |
| Q64057756 | MPSSS impairs the immunosuppressive function of cancer-associated fibroblasts via the TLR4-NF-κB pathway |
| Q37945300 | Macrophages in cancer and infectious diseases: the 'good' and the 'bad'. |
| Q37032307 | Melittin inhibits tumor angiogenesis modulated by endothelial progenitor cells associated with the SDF-1α/CXCR4 signaling pathway in a UMR-106 osteosarcoma xenograft mouse model |
| Q51533704 | Micro-volume wall-less immunoassays using patterned planar plates. |
| Q39505952 | Nef from SIV(mac239) decreases proliferation and migration of adenoid-cystic carcinoma cells and inhibits angiogenesis |
| Q53269695 | Neural differentiation of mesenchymal stem cells influences their chemotactic responses to stromal cell-derived factor-1α. |
| Q22000756 | Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis. |
| Q36039273 | Oxidative stress promotes myofibroblast differentiation and tumour spreading |
| Q92384299 | PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma |
| Q37421226 | Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein |
| Q37873925 | Peritoneal immune system in patients with advance epithelial ovarian cancer |
| Q94526733 | Plasma exo-hsa_circRNA_0056616: A potential biomarker for lymph node metastasis in lung adenocarcinoma |
| Q38825599 | Pomolic Acid Inhibits Invasion of Breast Cancer Cells Through the Suppression of CXC Chemokine Receptor Type 4 Expression |
| Q39255466 | Quantification of intact and truncated stromal cell-derived factor-1α in circulation by immunoaffinity enrichment and tandem mass spectrometry |
| Q92291013 | Radiation-Induced CXCL12 Upregulation via Histone Modification at the Promoter in the Tumor Microenvironment of Hepatocellular Carcinoma |
| Q33396653 | Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2. |
| Q38221172 | Regulation of chemokine expression in the tumor microenvironment |
| Q38481540 | Republished: Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology |
| Q92920986 | Reversing the Tumor Target: Establishment of a Tumor Trap |
| Q40119156 | Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia. |
| Q38268588 | Role of CXCL12 and CXCR4 in normal cerebellar development and medulloblastoma. |
| Q26796395 | Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation |
| Q58862468 | Role of Tumor-Associated Macrophages (TAM) in Cancer Related Inflammation |
| Q54365048 | Role of hERG1 K(+) channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation. |
| Q38340672 | Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis |
| Q36811212 | SDF1/CXCL12 is involved in recruitment of stem-like progenitor cells to orthotopic murine malignant mesothelioma spheroids |
| Q34936901 | Sarcoptes scabiei mites modulate gene expression in human skin equivalents |
| Q33623183 | Silencing of CXCR4 and CXCR7 expression by RNA interference suppresses human endometrial carcinoma growth in vivo |
| Q26765344 | Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II |
| Q38789459 | Slit-miR-218-Robo axis regulates retinal neovascularization |
| Q39161065 | Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer |
| Q39874056 | Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia |
| Q41891219 | Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2). |
| Q24313619 | Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8 |
| Q28078610 | Summary of emerging personalized medicine in neuroendocrine tumors: are we on track? |
| Q35033957 | Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination |
| Q35133083 | Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches |
| Q37901025 | Targeting of the innate immunity/inflammation as complementary anti-tumor therapies |
| Q37972797 | Targeting stroma to treat cancers |
| Q36144732 | The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells |
| Q36213484 | The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis |
| Q39886658 | The CXCR4/CXCL12 axis in endometrial cancer. |
| Q34146185 | The Effects of Tamoxifen in Combination with Tranilast on CXCL12-CXCR4 Axis and Invasion in Breast Cancer Cell Lines. |
| Q42411644 | The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis |
| Q38252537 | The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets. |
| Q28073437 | The application of the fibroblast activation protein α-targeted immunotherapy strategy |
| Q39180884 | The chemokine CXCL12 and its receptor CXCR4 are implicated in human seminoma metastasis |
| Q35858991 | The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer |
| Q37321944 | The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis. |
| Q51742979 | The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer |
| Q35067624 | The intricate role of CXCR4 in cancer |
| Q39524797 | The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells |
| Q36036905 | The role of SDF-1/CXCR4 in the vasculogenesis and remodeling of cerebral arteriovenous malformation |
| Q38129709 | The role of chemokines in acute and chronic hepatitis C infection |
| Q38079588 | The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas |
| Q90027887 | Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells |
| Q28397609 | Therapeutic cancer vaccines and combination immunotherapies involving vaccination |
| Q35647535 | Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma |
| Q34067863 | Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts |
| Q38016208 | Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention |
| Q42592787 | Will the Stroma-derived Factor-1α (CXCL12)/CXCR4 Pathway Become a Major Concern for Advanced Colorectal Cancer? |
Search more.